wet AMD - Classic CNVM mild vision loss
|
|
80 year old female She did not notice a problem but then when she saw you her vision in the right eye was hazy. The left eye was being watched because of eyelid herpes. The right eye has always been the weaker eye. She has not noticed a vision change in the right eye.
Shingles post-herpetic neuralgia over left eye for 2 years
VA OD: Dcc20/40+1 NccJ3
VA OS: Dcc20/25-2 NccJ1-1
IOP: TP: OD:17 OS:21
Anterior segment unremarkable (PCIOLs)
Vision improved to 20/25 after two Avastin shots and at 1 year she is getting treatment every 2 months
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 29280 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 26680 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 25980 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 28280 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 27180 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 25780 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 29080 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 26480 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 26380 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 26680 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 25780 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 27380 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 26080 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 26180 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 25580 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 29380 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 29780 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 28280 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 27780 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 26580 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 29780 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 24780 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 23380 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 27880 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 25080 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
|
|
|
|
|
80 year old female She did not notice a problem but then when she saw you her vision in the right eye was hazy. The left eye was being watched because of eyelid herpes. The right eye has always been the weaker eye. She has not noticed a vision change in the right eye.
Shingles post-herpetic neuralgia over left eye for 2 years
VA OD: Dcc20/40+1 NccJ3
VA OS: Dcc20/25-2 NccJ1-1
IOP: TP: OD:17 OS:21
Anterior segment unremarkable (PCIOLs)
Vision improved to 20/25 after two Avastin shots and at 1 year she is getting treatment every 2 months
